Cigarettes are smoked by over 1 billion people, which is nearly 20% of the world population. There is a gradual decline in smoking prevalence in areas of developed economy. For example, the smoking prevalence of Hong Kong people aged 15 or above dropped from 23.3% in 1982 to 10.5% in 2015. 1 Smoking is the single most important preventable risk factor for premature death and chronic diseases, including cancer and cardiovascular disease. Smokers die 13 years earlier than non-smokers. Smoking is responsible for 7,000 deaths and nearly 6 million deaths a year in Hong Kong and worldwide respectively. For various reasons, the prevalence of smoking is higher among patients than the general population. 30.7% of hospital patients were current smokers compared to the 21% of average population in UK. 2 The prevalence of smoking in patients with acute limb fractures was more than twice the general population in Australia. 3 The direct medical cost and indirect cost (loss of productivity from sick leaves and premature deaths) is up to 11.3 billion Hong Kong dollars a year. The direct medical cost of smoking accounts for 5.7% of global health expenditure and the indirect cost of smoking totaled to 1.8% of the world's annual gross domestic product (GDP). 4 Over 7,000 known toxins (70 of which are carcinogenic) are released and inhaled during smoking. These include nicotine, carbon monoxide and hydrogen cyanide etc. Carbon monoxide reduces oxygen carrying capacity of red blood cells and formation of carboxymyoglobin reduces oxygen storage in muscles. Hydrogen cyanide impedes cellular oxidative metabolism. Nicotine has multiple adverse effects including inhibition of osteoblast formation and function (impaired bone healing and non-union), impairment of wound and tendon healing (wound complications), impairment of immune response (wound infection), vasoconstriction, increased platelet adhesiveness (tissue hypoxia) and addiction. All these contribute to the increased risk of surgery in patients who smoke, whether current smoker or ever-smoker. Smoking exposes patients scheduled for surgery to risk increases of 20% in-hospital mortality and 40% in major complications including deep infection, pneumonia, unscheduled intubation, pulmonary embolism, ventilation >48 hours, stroke, coma >24 hours, cardiac arrest, myocardial infarction, transfusion >5 unit, sepsis, septic shock. 5 There is ample available evidence that current smoking increases complications in almost all type of surgery. Smoking is associated with surgical site infection and postoperative wound infection after spine surgery, total joint arthroplasty and fracture fixation; fracture non-union, non-union after spinal fusion, ankle fusion, osteotomy and internal fixation and bone grafting for scaphoid non-union; worse outcomes after spine surgery for lumbar disc prolapse, spinal stenosis and cervical myelopathy; periprosthetic joint infection and lower survivorship after total hip, knee arthroplasty, shoulder arthroplasty; worse outcomes after shoulder rotator cuff repair and anterior cruciate ligament reconstruction; and wound complication after microsurgery. 6 Fortunately, the half-life of nicotine and carbon monoxide and side effects usually last less than 12 hours after abstinence. Carbon monoxide is eliminated in the body by 24 hours and nicotine is eliminated by 48 hours after stop smoking. By a few weeks to 3 months, the circulation improves and lung function increase by up to 30%. The minimal time required for recovery of organ dysfunction after smoking cessation for wound healing is 3 to 4 weeks, 7 for bone healing is 4 weeks, 8 for immune competence is 2 to 6 weeks and for pulmonary function is 6 to 8 weeks. 9 For planned admissions, smoking cessation 8 weeks or more before admission is considered by National Health Service, UK as an optimum amount of time for the body to recover from the immediate effects of smoking. 10 The deleterious effects of smoking on the musculoskeletal system seem to be partially reversible and quitting smoking before operation mitigates the adverse effects of smoking on postoperative complications. There are high quality evidence showing the benefits of smoking cessation before surgery, specifically in total joint arthroplasty, fracture fixation and anterior cruciate ligament reconstruction.
A recent meta-analysis 11 of 6 randomized trials of preoperative smoking cessation demonstrated a relative reduction of 41% (95% confidence interval, CI 15e59, p ¼ 0.01) for prevention of postoperative complications. At least 4 weeks' preoperative smoking cessation had a significantly larger effect than a shorter duration (p ¼ 0.04). In the same meta-analysis, the pooled results from 12 observational studies showed significantly reductions in former smokers in total postoperative complications (relative risk, RR 0.76, 95% CI 0.69e0.84), pulmonary complications (RR 0.81, 95% CI 0.70e0.93) and wound healing (RR 0.73, 95% CI 0.61e0.87).
The great impact of preoperative smoking cessation on postoperative complications in total hip and knee joint arthroplasty was well demonstrated in a randomized controlled trial of 108 patients. 12 The intervention group received a 6 to 8 week program including counselling and nicotine replacement therapy before surgery, and either smoking cessation or at least 50% smoking reduction. Compared with the control group, the intervention group had significant fewer overall complications (one-third of that of control group: 5% vs. 31%, P ¼ 0.001) and less wound-related complications (only one-third, 18% vs. 52%, p ¼ 0.0003) with a trend, though statistically insignificant, of fewer cardiovascular complications and secondary surgery. Smoking cessation appeared to reverse the effects of smoking, as former smokers had perioperative complication rates and outcomes after total ankle arthroplasty similar to nonsmokers. 13 Smoking cessation intervention initiated during acute hospital stay and continued for 6 weeks postoperatively also benefits limb fracture surgery, as shown in another randomized controlled trial of 105 patients. The proportion of patients with at least one postoperative complication was significantly higher in the control group than in the intervention group (38% vs. 20%, p ¼ 0.048). The control group were 2.51 times (95% CI 0.96e6.9) more likely to have complications than the intervention group. 14 In anterior cruciate ligament reconstruction, those who had stopped smoking at least one month prior to anterior cruciate ligament reconstruction had no significant difference in outcomes compared with patients who had never smoke. 15 An orthopaedic operation, whether elective or emergency, gives a very special reason to quit smoking. Often, this is a "teachable moment" with an increased perceived risk associated with smoking when patients are more receptive to interventions and are more motivated to quit. 10 Such teachable moment does not last long. There is evidence that it does not persist even at first follow-up visit after an orthopaedic fracture. 16 It is recommended to stop smoking at least 4 to 6 weeks before surgery to lower the postoperative wound complication and pulmonary complications. Patients undergoing spine fusion surgery is recommend to quit smoking 4 weeks before and 6 months after surgery. 17 When a child has scheduled operation, the smoking parents are more likely to change their smoking behaviour. 18 Meta-analysis of environmental tobacco smoke exposure shows that the risk ratio for respiratory adverse events and laryngospasm is 1.75 and 3.54 respectively in the perianaesthetic period in children. 19 Reducing secondhanded smoke exposure of children before the elective surgery via parental smoking cessation or removal of children from environmental smoking before the elective surgery is recommended, 5 although it is yet to demonstrate whether changes in parental smoking behaviour prior to surgery reduces the risk of adverse anaesthetic and surgical outcomes in children. In practice, smoking parents are more ready to accept environmental tobacco smoke exposure mitigation than smoke quitting. 20 Smoking is not allowed in hospital and throughout the perioperative period. The no smoking hospital environment creates an external force to support abstinence. Take the chance to stop smoking earlier to prepare for the operation and take the chance to quit smoking to total abstinence. Within 2 weeks to 3 months of quitting, blood circulation improves and lung function increases by up to 30 percent. After 1 year of abstinence, the excessive risk of heart attack is reduced by half. After 1 year, there is an increased bone mineral density at hip in postmenopausal women. After 5 years, the risk of heart attack and stroke reduces to the same level of people who never smoke. After 10 years, the risk of hip fracture in women and the risk of developing rheumatoid arthritis reduce to that of a non-smoker. After 10 years of abstinence, the risk of lung cancer is half of that of continuing smokers, and continues to decline. After 10 to 15 years, the risk of dying almost returns to that of people who never smoke.
While waiting for an elective orthopaedic operation, quitting smoking is one of the most important things the patient can do to prevent perioperative complications. Each week of smoking cessation increased the magnitude of preventive effect on postoperative complication by 19%. 11 Thus, the early assessment of smoking status in orthopaedic patients and early referral to smoking cessation program can maximise the cessation period prior to surgery and ultimately quitting of smoking.
Many patients are willing to quit smoking before surgery. Once perceived as a habit of free choice, smoking now is considered a true drug dependency. Nicotine is more addictive than crack cocaine and heroin. Even a provision of brief advice from a clinician can increase the chance of quitting smoking when compared with no advice (relative risk 1.66, 95% CI 1.42e1.94). 21 The chance of quitting smoking is further enhanced by intensive counselling that begins during hospital stay and at least one month of supportive contact after discharge. 22 Combing drug treatment (including nicotine replacement therapy, bupropion, notriptyline or varenicline) and behavioural support increases cessation success rate than either behavioural support or drug treatment alone. 23 There is no evidence that printed-based self-help materials have an additional benefit when used with counselling intervention or pharmacotherapy. 24 With an integrated counselling and pharmacotherapy, the 7-day point prevalence abstinence rate at week 26 was reported as 35% by a local integrated centre on smoking cessation. 25 Orthopaedic surgeons should be aware of the adverse effects of smoking on the treatment of musculoskeletal disorders, educate patients about these negative effects and encourage and help patients to quit smoking. Such active role of orthopaedic surgeons in smoking cessation for orthopaedic patients is advocated by national health organizations, such as National Health System (NHS) of United Kingdom and American Academy of Orthopaedic Surgeons (AAOS). In the AAOS information statement "Tobacco Use and Orthopaedic Surgery", it states that AAOS recognizes active tobacco smoking is a significant surgical patient safety risk factor for adverse perioperative surgical events. Orthopaedic patients who are active smoker can reduce their risk of adverse surgical events by ceasing cigarette use prior to surgery. Orthopaedic surgeons are uniquely positioned to engage patients regarding these risks and provide education about the benefits of tobacco cessation supported by local smoking cessation programs to improve safety and outcomes following orthopaedic surgery. 26 Smoking cessation is regarded as equally important as surgeons' hand washing in reduction of perioperative complications. 27 The first surgeon who practices hand washing was Dr Ignaz Semmelweis in 1846. He saved many lives from puerperal fever in General Hospital in Vienna. Today, hand washing is still one of the most important ways to prevent hospital acquired infection. According to World Health Organization, clean care is safer care and hand hygiene supports surgical care. Hand washing and scrubbing before operation is a routine for surgeons doing any operation. Why not make smoking cessation as a routine in the preparation for an orthopaedic operation for your patient and offer smoking cessation interventions, similar to the osteoporosis treatment for the secondary prevention when you encounter an elderly with a fragility fracture.
